60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) currently has a daily average trading volume of 708.01K but it saw 822943 shares traded in last market. With a market cap of 3.38M USD, the company’s current market price of $1.91 came rising about 22.44 while comparing to the previous closing price of $1.56. In past 52 weeks, the stock remained buoying in the range of price level as high as $19.80 and as low as $1.03. In the recent trading on the day, stock has struck highest price mark of $1.57 while lowest mark touched by it was $1.99.
Taking a look at 20-day trading activity of 60 Degrees Pharmaceuticals Inc (SXTP) gives us an average price of $1.6193, while its current price level is -90.35% below from 52-week high level whereas it is 84.86% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.4650 while that of 200 days or SMA-200 reads an average of $4.8244. A closer look into the stock’s movement over the week reveals that its volatility is standing at 22.52% during that period while stretching the period over a month that decreases to 20.61%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 50.90 which implies that the stock is in neutral territory.
Over the week, SXTP’s stock price is moving 43.61% up while it is -13.68% when we observe its performance for the past one month. Year-to-date it is -84.40% down and over the past year, the stock is showing a downside performance of -89.53%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of 9.24 beaten by the consensus estimate of 11.4 for the same. The company is expected to be releasing its next quarterly report in September, for which analysts forecasted an EPS of -0.87 while estimate for next year EPS is -5.92. In next quarter, company is expected to be making quarterly sales of $230k as analysts are expecting the sales for current fiscal year at $590k and seeing the company making $1.8M in sales next year. Moreover, analysts are in estimates of $140k for current-quarter revenue.
Currently, 60 Degrees Pharmaceuticals Inc’s total number of outstanding shares is 1.77M. Company’s return on investment (ROI) stands at -55.00%. It has a price to earnings ratio (P/E ratio) of 3.01. Stock’s beta reads 4.69. Stock has a price to sale or P/S ratio amounts to 7.68. Its return on asset (ROA) is -25.91% on average.
